anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

212,821-212,880 of 319,975

filter-aware
64
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
65
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
66
Contains three images: the rocket launch, a long-exposure shot of the trajectory, and a rendering of the satellite in orbit.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
67
Slide 67 of a presentation.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
68
Includes a photo of the rocket launch and a rendering of the satellite in orbit.Eutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
69
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
70
Eutelsat | Investor Presentation Deck | 70 slidesEutelsat | Investor Presentation Deck | 70 slides · Eutelsat
Conference presentation Investor relations 1 hit
01
Slide 1
Includes company logo and date.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
02
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
03
The slide uses a grid of metrics to summarize the company's current status and business model.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Situation & ContextLoop · Golden Circle1 hit
04
The slide uses a dual-track timeline (Pipeline Progress vs Platform/Corporate) followed by a list of future goals.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Situation & Context1 hit
05
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
06
The central figure represents the patient, with six surrounding nodes representing different technological capabilities.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Solution1 hit
07
The slide uses a horizontal bar chart representation to show the stage of development for each program.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
08
The slide highlights the company's precision medicine approach to drug development.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
09
Uses a concentric circle diagram to categorize partnership benefits.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
10
The slide uses a stepped arrow timeline to show progression from known targets to challenging novel targets.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
11
The slide uses a 3x2 grid layout to present quantitative achievements.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
12
Includes footnote regarding fixed term bank deposits and shares outstanding.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
13
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
14
The slide uses a complex diagram combining a linear process flow with a double-loop feedback mechanism (flywheel).Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
15
The slide uses a circular process flow to represent a proprietary R&D pipeline.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
16
The slide uses a process flow diagram to illustrate a clinical case study.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Evidence & Proof1 hit
17
Kaplan-Meier survival analysis showing statistically significant improvement in PFS for matched treatments.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Evidence & Proof1 hit
18
The slide uses a horizontal process-like layout to showcase four distinct pillars of their R&D engine.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Evidence & Proof1 hit
19
The slide uses a circular flow diagram to represent the integration of experimental and AI-driven precision medicine.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
20
The slide highlights the integration of various data sources (Knowledge Graphs, Neural Networks, Literature/Patent Databases, Multi-omics, Vector Embedding) into a unified AI workflow.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
21
The slide uses a hierarchical clustering heatmap to visualize drug sensitivity across patient samples.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
22
The slide illustrates a drug discovery workflow using MPO (Multiparameter Optimisation) to balance multiple biological and chemical constraints.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
23
The diagram illustrates a multi-modal AI pipeline for drug discovery.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
24
The slide features a 3D molecular model and a UI overlay displaying various pharmacological parameters (potency, selectivity, stability, etc.) and a merit score.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
25
The chart illustrates a Pareto frontier where the AI selects compounds that are not necessarily the highest in potency but provide high information gain.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
26
The slide uses a series of dose-response curves to demonstrate differential drug sensitivity across patient samples.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
27
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
28
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
29
The visual depicts a molecular structure, likely representing the drug candidate or its target.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
30
MTD = Maximum Tolerated Dose; ORR = Objective Response Rate; ABS = Adenosine Burden Score.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Visualization1 hit
31
The slide uses a human anatomy diagram to map patient counts to specific disease locations.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Visualization1 hit
32
The slide shows a heatmap of 43 patient samples across different cancer types, correlating ABS with signature scores.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
33
The slide presents two distinct sets of data: a comparative line chart (left) and a series of box-and-whisker plots (right) showing performance across different cell types.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
34
The slide uses a combination of bar charts and scatter plots to demonstrate the inverse relationship between ABS and TIS.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
35
The slide presents two line/box plots showing dose-dependent responses to stabilised adenosine.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
36
The slide presents two key clinical data plots: a pharmacodynamic correlation (exposure vs inhibition) and a pharmacokinetic profile (concentration over time).Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
37
The slide features a 3D molecular visualization of the inhibitor.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
38
The slide outlines a standard oncology clinical trial design (Dose Escalation to RP2D to Dose Expansion).Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
39
The slide uses a human anatomy diagram to map specific cancer types to their respective incidence numbers.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
40
Includes a biological pathway diagram and a honeycomb-style indication map.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
41
The slide uses a three-column layout to define the target product profile (TPP) requirements for a drug candidate.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
42
The table uses a color-coded system (green/yellow/red) to indicate performance against criteria.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
43
Data source: Besnard et al, AACR (2022).Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
44
The waterfall plot shows drug response scores across many samples, indicating sensitivity. The right side summarizes findings and the rationale for combination testing.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
45
The slide uses a heatmap to display binary synergy results (Yes/No) across three drug combinations, alongside a bar chart showing single-agent sensitivity.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
46
The slide uses a Venn diagram to illustrate the overlap of gene modulation between peripheral blood and primary tumours, and line charts to show dose-response curves for two specific biomarkers.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
47
The slide features a 3D molecular visualization of the protein target.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
48
TPP stands for Target Product Profile.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
49
The slide uses a traffic-light color coding system to highlight performance against criteria.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
50
The slide uses a process-flow layout to describe the company's R&D methodology.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
51
The visual background is a stylized molecular structure, emphasizing the biotech/pharma context.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
52
Exscientia | Investor Presentation Deck | 75 slidesExscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
53
Includes two scientific diagrams illustrating the mechanism of action and brain penetration.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit